F 26" Wheelset Downhill Bike Mountain DH MASSIF COLE 20x110 12x150 R Wheels & Wheelsets


  1. Home
  2. F 26" Wheelset Downhill Bike Mountain DH MASSIF COLE 20x110 12x150 R
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
COLE MASSIF DH Mountain Bike Downhill  Wheelset 26" F 20x110 R 12x150
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Brand:

CyclingDeal

Manufacturer Part Number:

OT-WH-COLE-04

MPN:

OT-WH-COLE-04

UPC:

9504157114401

EAN:

9504157114401




published on tue nov 09 2021

F 26" Wheelset Downhill Bike Mountain DH MASSIF COLE 20x110 12x150 R Wheels & Wheelsets

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

F 26" Wheelset Downhill Bike Mountain DH MASSIF COLE 20x110 12x150 R Wheels & Wheelsets

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS